Skip to main content
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
EN
FR
EN
PT
NL
NB
DE
IT
Home
Company Press Releases
Company press releases
Subscribe
Filters
Filters
Refresh
Reset
Icon After
Date
Toggle Visibility
All
Today
This week
This month
Custom date range
From
To
Topic
Toggle Visibility
Acquisition or disposal of the issuer’s own shares
Additional regulated information required to be disclosed under the laws of a Member State
Adjustment of interest rate
Alliances and agreements
Annual financial and audit Reports
Change in Capital
Changes in the rights attaching to the classes of shares or securities
Commercial operations
Commercial results
Corporate life
Dividend
Ex Date
General meeting / Board Meeting
Half yearly financial reports and audit reports/limited reviews
Home Member State
Income
Inside information
Joint venture
Journal / appointments
Legal
Major shareholding notifications
Mandatory notification of trade primary insiders
Meetings / events
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Non-regulatory press releases
Other financial transaction
Other subject
Payments to governments
Polls / Surveys
Products and services
Prospectus / admission document
Rating
Sales
Share history
Share introduction and issues
Takeover bids
Total number of voting rights and capital
Trends / Analyses
Provider
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Displaying 151 - 169 of 169 results
Released
Company
Title
Industry
Topic
28 Jun 2021
19:59 CEST
AB SCIENCE
AB Science annonce aujourd’hui la signature d’un accord avec des actionnaires historiques en vue de mettre en œuvre une stratégie commune de valorisation du masitinib
20103010 Biotechnology
New
10 Jun 2021
18:54 CEST
AB SCIENCE
AB Science today announced that results from masitinib study AB12005 in pancreatic cancer have been presented at the 2021 ASCO Annual Meeting
20103010 Biotechnology
New
10 Jun 2021
18:54 CEST
AB SCIENCE
AB Science annonce aujourd'hui que les résultats de l’étude AB12005 du masitinib dans le cancer du pancréas ont été présentés à la réunion annuelle 2021 de l'ASCO
20103010 Biotechnology
New
08 Jun 2021
08:30 CEST
AB SCIENCE
AB Science is providing a summary of the live webcast held on June 3, 2021 following the voluntary hold in the clinical studies of masitinib
20103010 Biotechnology
New
08 Jun 2021
08:30 CEST
AB SCIENCE
AB Science fournit le résumé de la conférence virtuelle qui s’est tenue le 3 juin 2021 suite à l’interruption volontaire des études cliniques du masitinib
20103010 Biotechnology
New
02 Jun 2021
15:32 CEST
AB SCIENCE
AB Science will host a live webcast on June 3, 2021 following the voluntary hold in the clinical studies of masitinib
20103010 Biotechnology
New
02 Jun 2021
15:32 CEST
AB SCIENCE
AB Science tiendra une conférence virtuelle le jeudi 3 juin 2021 suite à l'annonce de l'interruption volontaire des études cliniques du masitinib
20103010 Biotechnology
New
01 Jun 2021
06:59 CEST
AB SCIENCE
AB Science announces a voluntary hold in the clinical studies of masitinib worldwide
20103010 Biotechnology
New
01 Jun 2021
06:59 CEST
AB SCIENCE
AB Science annonce l'interruption volontaire des études cliniques du masitinib au niveau mondial
20103010 Biotechnology
New
26 May 2021
19:18 CEST
AB SCIENCE
AB Science communique les résultats de l'étude de Phase 3 évaluant le masitinib dans le cancer de la prostate
20103010 Biotechnology
New
26 May 2021
19:18 CEST
AB SCIENCE
AB Science communicates results from Phase 3 study evaluating masitinib in prostate cancer
20103010 Biotechnology
New
21 May 2021
18:01 CEST
AB SCIENCE
AB Science tiendra une conférence virtuelle le mardi 25 mai 2021 sur les résultats du masitinib dans le cancer de la prostate
20103010 Biotechnology
New
21 May 2021
18:01 CEST
AB SCIENCE
AB Science will host a live webcast on Tuesday May 25, 2021 on masitinib results in Prostate Cancer
20103010 Biotechnology
New
20 May 2021
18:06 CEST
AB SCIENCE
AB Science annonce aujourd'hui que les résultats de l’étude AB12005 du masitinib dans le cancer du pancréas ont été sélectionnés pour être présentés à la prochaine réunion annuelle de l'ASCO.
20103010 Biotechnology
New
20 May 2021
18:06 CEST
AB SCIENCE
AB Science today announced that results from masitinib study AB12005 in pancreatic cancer, have been selected for presentation at the upcoming ASCO Annual Meeting
20103010 Biotechnology
New
30 Apr 2021
18:45 CEST
AB SCIENCE
AB Science reports today its annual financials as of 31 December 2020 and provides an update on its activities
20103010 Biotechnology
Income
30 Apr 2021
18:45 CEST
AB SCIENCE
AB Science annonce aujourd’hui ses résultats financiers annuels arrêtés au 31 décembre 2020 et présente l’actualité de ses activités
20103010 Biotechnology
Income
29 Apr 2021
19:05 CEST
AB SCIENCE
AB Science today announced that its masitinib Phase 2B/3 study (AB12003) in metastatic castrate-resistant prostate cancer (mCRPC) met its predefined primary endpoint
20103010 Biotechnology
New
29 Apr 2021
19:05 CEST
AB SCIENCE
AB Science annonce aujourd'hui que l'étude de phase 2B/3 (AB12003) du masitinib dans le cancer de la prostate métastatique hormono-résistant (mCRPC) a atteint son critère d'évaluation principal prédéfi
20103010 Biotechnology
New
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Pagination
«
« First
‹
‹‹
2
3
4
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
your account
section or
create an account
.
Home
Markets
Amsterdam
Cash Products
Stocks
AEX index Stocks
AEX ESG Stocks
Indices
Funds
Bonds
ETFs
Structured products
Derivative products
Index options
Index futures
Stock options
Dividend derivatives
Stock futures
Quote Vendor Codes
Company regulated news
Latest
Archive
Brussels
Cash products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indices
Bonds
ETFs
Structured Products
Derivative products
Index futures
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisbon
Cash Products
Stocks
Euronext regulated
Euronext Access
PSI Stocks
Indices
Bonds
Derivative products
Index futures
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Cash Products
Stocks
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX stocks
OBX ESG Stocks
OSEBX stocks
OSEFX Stocks
Seafood Stocks
Shipping Stocks
Equity indices
Bonds
Oslo Børs
Nordic Alternative Bond Market
Bond indices
ETFs
Funds
Derivatives
Derivative products
Quote Vendor Codes
Company regulated news
Latest
Archive
Financial calendars
Primary insiders
Paris
Cash Products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indices
Bonds
ETFs
Structured products
Derivative products
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Equities
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Company regulated news
Latest
Archive
IPOs
All IPOs
Listing sponsors
Euronext Tech Leaders
Family business
Indices
Directory
ESG indices
Indices documents
Indices news
Index consultations
Contact Euronext indices
ETFs
Directory
ESG ETFs
Funds
Directory
ESG Funds
Oslo Mutual Funds
Fixed Income
ESG Bonds
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Structured Products
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Equity Derivatives
Index Futures
Index Options
Stock Options
Stock Futures
Dividend Derivatives
ETF Options
Contracts specifications
Tick Sizes
Wholesale Trading
Quote vendor codes
Commodities
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Trading calendars
Delivery
Wholesale Trading
Commitments of Traders (CoT) report
Contracts specifications
Quote vendor codes
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Resources
Statistics & reports
Quality of execution
Trading hours & Holidays
Contract specifications
Quote vendor codes
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Market events
Suspended instruments
Stressed Market Conditions
Breach of Double Cap limits
Exceptional Market Conditions
Miscellaneous short messages
Market status
Members list
Issuers compliance
Where to find